Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F23211)

Formulation Name

Linagliptin 5mg tablet

Company

Boehringer Ingelheim

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Linagliptin	DMWFJTR	Non-insulin dependent diabetes	5A11	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Copovidone	E00693	Not Available	Film/membrane-forming agent; Modified-release agent; Binding agent
Haematite red	E00236	14833	Colorant
Hypromellose	E00634	Not Available	Coating agent
Magnesium stearate	E00208	11177	lubricant
Mannitol	E00103	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000	E00654	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Pregelatinized starch	E00674	Not Available	Binding agent; Diluent; Disintegrant
Talc	E00520	16211421	Anticaking agent; Diluent; Glidant; lubricant

--------------------